Kenmerk
Low levels of amniotic fluid
Klinische naam: Oligohydramnios
Diminished amniotic fluid volume in pregnancy.
Samenvatting
- Ook bekend als
- Maternal oligohydramnios
- Lichaamssysteem
- Abnormality of prenatal development or birth
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Low levels of amniotic fluid, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen209 genen gekoppeld aan Low levels of amniotic fluid
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Low levels of amniotic fluid voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| BNIP1BCL2 interacting protein 1 | Altijd | In 1 aandoening |
| CEP55centrosomal protein 55 | Altijd | In 1 aandoening |
| COX14cytochrome c oxidase assembly factor COX14 | Altijd | In 1 aandoening |
| DALRD3DALR anticodon binding domain containing 3 | Altijd | In 1 aandoening |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Altijd | In 1 aandoening |
| EXOC3L2exocyst complex component 3 like 2 | Altijd | In 1 aandoening |
| FARSAphenylalanyl-tRNA synthetase subunit alpha | Altijd | In 1 aandoening |
| FARSBphenylalanyl-tRNA synthetase subunit beta | Altijd | In 1 aandoening |
| IARS1isoleucyl-tRNA synthetase 1 | Altijd | In 2 aandoeningen |
| LARS2leucyl-tRNA synthetase 2, mitochondrial | Altijd | In 1 aandoening |
| LRRC7leucine rich repeat containing 7 | Altijd | In 1 aandoening |
| MED16mediator complex subunit 16 | Altijd | In 1 aandoening |
| MYH11myosin heavy chain 11 | Altijd | In 1 aandoening |
| MYL9myosin light chain 9 | Altijd | In 1 aandoening |
| NDUFB7NADH:ubiquinone oxidoreductase subunit B7 | Altijd | In 1 aandoening |
| PDX1pancreatic and duodenal homeobox 1 | Altijd | In 1 aandoening |
| RCC1regulator of chromosome condensation 1 | Altijd | In 1 aandoening |
| RNU5B-1RNA, U5B small nuclear 1 | Altijd | In 1 aandoening |
| SLC25A24solute carrier family 25 member 24 | Altijd | In 1 aandoening |
| TMEM231transmembrane protein 231 | Altijd | In 2 aandoeningen |
| TRA2Btransformer 2 beta homolog | Altijd | In 1 aandoening |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Altijd | In 1 aandoening |
| UQCC2ubiquinol-cytochrome c reductase complex assembly factor 2 | Altijd | In 1 aandoening |
| WNT4Wnt family member 4 | Altijd | In 2 aandoeningen |
| ZMPSTE24zinc metallopeptidase STE24 | Altijd | In 1 aandoening |
| FGF20fibroblast growth factor 20 | Heel vaak (80–99%) | In 1 aandoening |
| GFRA1GDNF family receptor alpha 1 | Heel vaak (80–99%) | In 1 aandoening |
| GREB1LGREB1 like retinoic acid receptor coactivator | Heel vaak (80–99%) | In 1 aandoening |
| HYMAIhydatidiform mole associated and imprinted | Heel vaak (80–99%) | In 1 aandoening |
| ITGA8integrin subunit alpha 8 | Heel vaak (80–99%) | In 2 aandoeningen |
| PLAGL1PLAG1 like zinc finger 1 | Heel vaak (80–99%) | In 1 aandoening |
| RETret proto-oncogene | Heel vaak (80–99%) | In 2 aandoeningen |
| TCTN3tectonic family member 3 | Heel vaak (80–99%) | In 2 aandoeningen |
| TMEM70transmembrane protein 70 | Heel vaak (80–99%) | In 2 aandoeningen |
| WNT9BWnt family member 9B | Heel vaak (80–99%) | In 1 aandoening |
| ACTG2actin gamma 2, smooth muscle | Vaak (30–79%) | In 1 aandoening |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Vaak (30–79%) | In 2 aandoeningen |
| ALX4ALX homeobox 4 | Vaak (30–79%) | In 2 aandoeningen |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Vaak (30–79%) | In 1 aandoening |
| B9D1B9 domain containing 1 | Vaak (30–79%) | In 1 aandoening |
Toon nog 169 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| B9D2B9 domain containing 2 | Vaak (30–79%) | In 1 aandoening |
| BIN1bridging integrator 1 | Vaak (30–79%) | In 1 aandoening |
| C1QBPcomplement C1q binding protein | Vaak (30–79%) | In 1 aandoening |
| CC2D2Acoiled-coil and C2 domain containing 2A | Vaak (30–79%) | In 1 aandoening |
| CDKN1Ccyclin dependent kinase inhibitor 1C | Vaak (30–79%) | In 1 aandoening |
| CEP290centrosomal protein 290 | Vaak (30–79%) | In 1 aandoening |
| CERT1ceramide transporter 1 | Vaak (30–79%) | In 1 aandoening |
| CHRM3cholinergic receptor muscarinic 3 | Vaak (30–79%) | In 2 aandoeningen |
| CSPP1centrosome and spindle pole associated protein 1 | Vaak (30–79%) | In 1 aandoening |
| DEF6DEF6 guanine nucleotide exchange factor | Vaak (30–79%) | In 1 aandoening |
| DOCK6dedicator of cytokinesis 6 | Vaak (30–79%) | In 1 aandoening |
| DSTdystonin | Vaak (30–79%) | In 2 aandoeningen |
| DZIP1LDAZ interacting zinc finger protein 1 like | Vaak (30–79%) | In 1 aandoening |
| EBF3EBF transcription factor 3 | Vaak (30–79%) | In 1 aandoening |
| FREM2FRAS1 related extracellular matrix 2 | Vaak (30–79%) | In 1 aandoening |
| GRIP1glutamate receptor interacting protein 1 | Vaak (30–79%) | In 1 aandoening |
| H19H19 imprinted maternally expressed transcript | Vaak (30–79%) | In 1 aandoening |
| HBA1hemoglobin subunit alpha 1 | Vaak (30–79%) | In 1 aandoening |
| HBA2hemoglobin subunit alpha 2 | Vaak (30–79%) | In 1 aandoening |
| HMGA2high mobility group AT-hook 2 | Vaak (30–79%) | In 1 aandoening |
| IFIH1interferon induced with helicase C domain 1 | Vaak (30–79%) | In 1 aandoening |
| IGF2insulin like growth factor 2 | Vaak (30–79%) | In 3 aandoeningen |
| KIF14kinesin family member 14 | Vaak (30–79%) | In 1 aandoening |
| LAMB2laminin subunit beta 2 | Vaak (30–79%) | In 2 aandoeningen |
| LIFRLIF receptor subunit alpha | Vaak (30–79%) | In 2 aandoeningen |
| MKS1MKS transition zone complex subunit 1 | Vaak (30–79%) | In 2 aandoeningen |
| MTO1mitochondrial tRNA translation optimization 1 | Vaak (30–79%) | In 1 aandoening |
| NEK8NIMA related kinase 8 | Vaak (30–79%) | In 2 aandoeningen |
| NOTCH3notch receptor 3 | Vaak (30–79%) | In 1 aandoening |
| NPHP3nephrocystin 3 | Vaak (30–79%) | In 4 aandoeningen |
| PAX2paired box 2 | Vaak (30–79%) | In 1 aandoening |
| PBX1PBX homeobox 1 | Vaak (30–79%) | In 2 aandoeningen |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Vaak (30–79%) | In 2 aandoeningen |
| PLAG1PLAG1 zinc finger | Vaak (30–79%) | In 1 aandoening |
| RBM10RNA binding motif protein 10 | Vaak (30–79%) | In 1 aandoening |
| RNF2ring finger protein 2 | Vaak (30–79%) | In 1 aandoening |
| RPGRIP1RPGR interacting protein 1 | Vaak (30–79%) | In 1 aandoening |
| RPGRIP1LRPGRIP1 like | Vaak (30–79%) | In 1 aandoening |
| SFXN4sideroflexin 4 | Vaak (30–79%) | In 1 aandoening |
| SV2Asynaptic vesicle glycoprotein 2A | Vaak (30–79%) | In 1 aandoening |
| SZT2SZT2 subunit of KICSTOR complex | Vaak (30–79%) | In 1 aandoening |
| TCTN1tectonic family member 1 | Vaak (30–79%) | In 1 aandoening |
| TCTN2tectonic family member 2 | Vaak (30–79%) | In 1 aandoening |
| TMEM107transmembrane protein 107 | Vaak (30–79%) | In 1 aandoening |
| TMEM216transmembrane protein 216 | Vaak (30–79%) | In 1 aandoening |
| TMEM237transmembrane protein 237 | Vaak (30–79%) | In 1 aandoening |
| TMEM67transmembrane protein 67 | Vaak (30–79%) | In 1 aandoening |
| TPI1triosephosphate isomerase 1 | Vaak (30–79%) | In 1 aandoening |
| TRIP4thyroid hormone receptor interactor 4 | Vaak (30–79%) | In 1 aandoening |
| TXNDC15thioredoxin domain containing 15 | Vaak (30–79%) | In 2 aandoeningen |
| ALBalbumin | Soms (5–29%) | In 2 aandoeningen |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Soms (5–29%) | In 2 aandoeningen |
| ASCL1achaete-scute family bHLH transcription factor 1 | Soms (5–29%) | In 1 aandoening |
| ATN1atrophin 1 | Soms (5–29%) | In 1 aandoening |
| B3GALT6beta-1,3-galactosyltransferase 6 | Soms (5–29%) | In 1 aandoening |
| BRCA1BRCA1 DNA repair associated | Soms (5–29%) | In 1 aandoening |
| BRCA2BRCA2 DNA repair associated | Soms (5–29%) | In 1 aandoening |
| BRIP1BRCA1 interacting DNA helicase 1 | Soms (5–29%) | In 1 aandoening |
| CA2carbonic anhydrase 2 | Soms (5–29%) | In 1 aandoening |
| CDC42BPBCDC42 binding protein kinase beta | Soms (5–29%) | In 1 aandoening |
| CLTCL1clathrin heavy chain like 1 | Soms (5–29%) | In 1 aandoening |
| COG5component of oligomeric golgi complex 5 | Soms (5–29%) | In 1 aandoening |
| COL25A1collagen type XXV alpha 1 chain | Soms (5–29%) | In 1 aandoening |
| CPT2carnitine palmitoyltransferase 2 | Soms (5–29%) | In 1 aandoening |
| CRELD1CRELD disulfide isomerase 1 | Soms (5–29%) | In 1 aandoening |
| DDX6DEAD-box helicase 6 | Soms (5–29%) | In 1 aandoening |
| DHPSdeoxyhypusine synthase | Soms (5–29%) | In 1 aandoening |
| DPF2double PHD fingers 2 | Soms (5–29%) | In 1 aandoening |
| DSPdesmoplakin | Soms (5–29%) | In 1 aandoening |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Soms (5–29%) | In 2 aandoeningen |
| ELFN1extracellular leucine rich repeat and fibronectin type III domain containing 1 | Soms (5–29%) | In 1 aandoening |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Soms (5–29%) | In 1 aandoening |
| ERGIC1endoplasmic reticulum-golgi intermediate compartment 1 | Soms (5–29%) | In 1 aandoening |
| FAAP100FA core complex associated protein 100 | Soms (5–29%) | In 1 aandoening |
| FANCAFA complementation group A | Soms (5–29%) | In 1 aandoening |
| FANCBFA complementation group B | Soms (5–29%) | In 1 aandoening |
| FANCCFA complementation group C | Soms (5–29%) | In 1 aandoening |
| FANCD2FA complementation group D2 | Soms (5–29%) | In 1 aandoening |
| FANCEFA complementation group E | Soms (5–29%) | In 1 aandoening |
| FANCFFA complementation group F | Soms (5–29%) | In 1 aandoening |
| FANCGFA complementation group G | Soms (5–29%) | In 1 aandoening |
| FANCIFA complementation group I | Soms (5–29%) | In 1 aandoening |
| FANCLFA complementation group L | Soms (5–29%) | In 1 aandoening |
| FANCMFA complementation group M | Soms (5–29%) | In 1 aandoening |
| FBXO22F-box protein 22 | Soms (5–29%) | In 1 aandoening |
| FHfumarate hydratase | Soms (5–29%) | In 1 aandoening |
| FILIP1filamin A interacting protein 1 | Soms (5–29%) | In 1 aandoening |
| FRA10AC1FRA10A associated CGG repeat 1 | Soms (5–29%) | In 1 aandoening |
| FXR1FMR1 autosomal homolog 1 | Soms (5–29%) | In 2 aandoeningen |
| GATA6GATA binding protein 6 | Soms (5–29%) | In 1 aandoening |
| GMPPBGDP-mannose pyrophosphorylase B | Soms (5–29%) | In 1 aandoening |
| GNB2G protein subunit beta 2 | Soms (5–29%) | In 1 aandoening |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Soms (5–29%) | In 1 aandoening |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Soms (5–29%) | In 1 aandoening |
| HIVEP2HIVEP zinc finger 2 | Soms (5–29%) | In 1 aandoening |
| HNF1BHNF1 homeobox B | Soms (5–29%) | In 1 aandoening |
| HS2ST1heparan sulfate 2-O-sulfotransferase 1 | Soms (5–29%) | In 1 aandoening |
| INPPL1inositol polyphosphate phosphatase like 1 | Soms (5–29%) | In 1 aandoening |
| JUPjunction plakoglobin | Soms (5–29%) | In 1 aandoening |
| LHX1LIM homeobox 1 | Soms (5–29%) | In 1 aandoening |
| MAD2L2mitotic arrest deficient 2 like 2 | Soms (5–29%) | In 1 aandoening |
| MAGEL2MAGE family member L2 | Soms (5–29%) | In 1 aandoening |
| MKRN3makorin ring finger protein 3 | Soms (5–29%) | In 1 aandoening |
| MYH3myosin heavy chain 3 | Soms (5–29%) | In 2 aandoeningen |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Soms (5–29%) | In 1 aandoening |
| NALCNsodium leak channel, non-selective | Soms (5–29%) | In 1 aandoening |
| NDUFA6NADH:ubiquinone oxidoreductase subunit A6 | Soms (5–29%) | In 1 aandoening |
| NEK9NIMA related kinase 9 | Soms (5–29%) | In 1 aandoening |
| NPAP1nuclear pore associated protein 1 | Soms (5–29%) | In 1 aandoening |
| PALB2partner and localizer of BRCA2 | Soms (5–29%) | In 1 aandoening |
| PGAP2post-GPI attachment to proteins 2 | Soms (5–29%) | In 1 aandoening |
| PGAP3post-GPI attachment to proteins phospholipase 3 | Soms (5–29%) | In 1 aandoening |
| PHOX2Bpaired like homeobox 2B | Soms (5–29%) | In 1 aandoening |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Soms (5–29%) | In 1 aandoening |
| PIGOphosphatidylinositol glycan anchor biosynthesis class O | Soms (5–29%) | In 1 aandoening |
| PIGVphosphatidylinositol glycan anchor biosynthesis class V | Soms (5–29%) | In 1 aandoening |
| PIGWphosphatidylinositol glycan anchor biosynthesis class W | Soms (5–29%) | In 1 aandoening |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Soms (5–29%) | In 1 aandoening |
| PUF60poly(U) binding splicing factor 60 | Soms (5–29%) | In 1 aandoening |
| PWAR1Prader Willi/Angelman region RNA 1 | Soms (5–29%) | In 1 aandoening |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Soms (5–29%) | In 1 aandoening |
| RAD51RAD51 recombinase | Soms (5–29%) | In 1 aandoening |
| RAD51CRAD51 paralog C | Soms (5–29%) | In 1 aandoening |
| RFWD3ring finger and WD repeat domain 3 | Soms (5–29%) | In 1 aandoening |
| RHAGRh associated glycoprotein | Soms (5–29%) | In 1 aandoening |
| RHCERh blood group CcEe antigens | Soms (5–29%) | In 1 aandoening |
| RHDRh blood group D antigen | Soms (5–29%) | In 1 aandoening |
| SATB1SATB homeobox 1 | Soms (5–29%) | In 1 aandoening |
| SCYL2SCY1 like pseudokinase 2 | Soms (5–29%) | In 1 aandoening |
| SEC61A1SEC61 translocon subunit alpha 1 | Soms (5–29%) | In 1 aandoening |
| SETD1ASET domain containing 1A, histone lysine methyltransferase | Soms (5–29%) | In 1 aandoening |
| SLC35A2solute carrier family 35 member A2 | Soms (5–29%) | In 1 aandoening |
| SLX4SLX4 structure-specific endonuclease subunit | Soms (5–29%) | In 1 aandoening |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Soms (5–29%) | In 1 aandoening |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Soms (5–29%) | In 1 aandoening |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Soms (5–29%) | In 1 aandoening |
| TBCKTBC1 domain containing kinase | Soms (5–29%) | In 2 aandoeningen |
| UBE2Aubiquitin conjugating enzyme E2 A | Soms (5–29%) | In 1 aandoening |
| UBE2Tubiquitin conjugating enzyme E2 T | Soms (5–29%) | In 1 aandoening |
| VIPAS39VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog | Soms (5–29%) | In 1 aandoening |
| VPS33BVPS33B late endosome and lysosome associated | Soms (5–29%) | In 2 aandoeningen |
| WBP4WW domain binding protein 4 | Soms (5–29%) | In 1 aandoening |
| WSB2WD repeat and SOCS box containing 2 | Soms (5–29%) | In 1 aandoening |
| XRCC2X-ray repair cross complementing 2 | Soms (5–29%) | In 1 aandoening |
| ZFXzinc finger protein X-linked | Soms (5–29%) | In 1 aandoening |
| BNC2basonuclin zinc finger protein 2 | Zelden (1–4%) | In 1 aandoening |
| DONSONDNA replication fork stabilization factor DONSON | Zelden (1–4%) | In 2 aandoeningen |
| GLI3GLI family zinc finger 3 | Zelden (1–4%) | In 1 aandoening |
| ACEangiotensin I converting enzyme | Niet vastgelegd | In 1 aandoening |
| AGTangiotensinogen | Niet vastgelegd | In 1 aandoening |
| AGTR1angiotensin II receptor type 1 | Niet vastgelegd | In 1 aandoening |
| AMER1APC membrane recruitment protein 1 | Niet vastgelegd | In 1 aandoening |
| BMPERBMP binding endothelial regulator | Niet vastgelegd | In 1 aandoening |
| BUB1BBUB1 mitotic checkpoint serine/threonine kinase B | Niet vastgelegd | In 1 aandoening |
| COQ7coenzyme Q7, hydroxylase | Niet vastgelegd | In 1 aandoening |
| EXOSC9exosome component 9 | Niet vastgelegd | In 1 aandoening |
| FBLN5fibulin 5 | Niet vastgelegd | In 1 aandoening |
| FBN1fibrillin 1 | Niet vastgelegd | In 1 aandoening |
| HSPA9heat shock protein family A (Hsp70) member 9 | Niet vastgelegd | In 1 aandoening |
| INVSinversin | Niet vastgelegd | In 1 aandoening |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Niet vastgelegd | In 1 aandoening |
| MYLKmyosin light chain kinase | Niet vastgelegd | In 1 aandoening |
| OSGEPO-sialoglycoprotein endopeptidase | Niet vastgelegd | In 1 aandoening |
| PORcytochrome p450 oxidoreductase | Niet vastgelegd | In 1 aandoening |
| RENrenin | Niet vastgelegd | In 1 aandoening |
| RNU4ATACRNA, U4atac small nuclear | Niet vastgelegd | In 1 aandoening |
| SEC24DSEC24 homolog D, COPII component | Niet vastgelegd | In 1 aandoening |
| TALDO1transaldolase 1 | Niet vastgelegd | In 1 aandoening |
| WDR73WD repeat domain 73 | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken